Herbicides à base de glyphosate et enjeux de droits pour la santé, le travail et les dispositifs évaluatifs et réglementaire

In 2015, France recognized hematological malignancies, including non-Hodgkin's lymphoma (NHL), as an occupational disease resulting from pesticide exposure. The IARC of the WHO then declared glyphosate and glyphosate-based herbicides to be genotoxic and probably carcinogenic. In the United States, 125,000 American victims of NHL attributed to Bayer-Monsanto's Roundup have filed lawsuits against the company, while 2.5 million pages of declassified internal documents, the Monsanto Papers, illustrated the incredible manipulations to conceal Roundup’s dangers and to subvert the evaluation and regulatory systems. After three costly convictions, Bayer-Monsanto signed a partial out-of-court settlement of $11 billion and withdrew Roundup from the U.S. domestic market. The structural increase in pesticides, from 2.3 to 4.1 million tons from 1990 to 2018, contributing to the 385 million cases per year of serious and unintentional poisoning, and their threatening impacts on the climate, biodiversity and planetary limits, require going beyond the compensation of certain diseases to highlight the responsibilities of producing firms, regulatory bodies and public authorities : This is the core of this article focused on glyphosate-based herbicides (HBC), the first pesticides in the world, in Canada and Quebec and their links with certain cancers, including non-Hodgkin's lymphoma (NHL).